Skip to main content

Advertisement

Log in

Extracellular volume fraction by T1 mapping predicts improvement of left ventricular ejection fraction after catheter ablation in patients with non-ischemic dilated cardiomyopathy and atrial fibrillation

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

Absence of myocardial fibrosis on late gadolinium enhanced (LGE) magnetic resonance imaging (MRI) is associated with improvement of left ventricular systolic function after catheter ablation (CA) for atrial fibrillation (AF) with non-ischemic dilated cardiomyopathy (NIDCM). Extracellular volume fraction (ECV) by T1 mapping has emerges as a non-invasive mean to quantify severity of myocardial fibrosis. The aim of this study was to assess the incremental value of ECV over LGE-MRI for the improvement of LVEF(∆EF) after CA in NIDCM patients. A total of thirty-two patients with NIDCM and AF (mean age 67.4 ± 9.3 years; 29 (91%) male) were retrospectively studied. Using a 1.5 T MR scanner and 32 channel cardiac coils, LGE-MRI, pre- and post-T1 mapping images of LV wall at mid-ventricular level (modified look-locker inversion recovery sequence) were acquired. All patients successfully underwent CA for AF, and the improvement of LVEF after CA were evaluated by echocardiography. All patients restored sinus rhythm after CA at the time of echocardiography. The mean LVEF was 35.1 ± 9.7% before CA and 52.2 ± 10.2% after CA (p < 0.001), resulting an increase of 17.4 ± 12.6%. Significant correlation was found between ∆LVEF and % LGE (r = − 0.49, p = 0.004), ∆LVEF and extracellular volume fraction (ECV) (r = − 0.47, p = 0.010). Area under the receiver operating characteristics curve (AUC) of combination of %LGE and ECV for predicting improvement of LVEF > 10% was substantially higher than that of %LGE alone (AUC: 0.830 vs 0.602). In NIDCM patients with AF, ECV had incremental value over %LGE for predicting improvement of EF by CA, suggesting that the assessment of diffuse interstitial fibrosis may be important to forecast the response of CA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

AUC:

Area under the curve

AF:

Atrial fibrillation

CA:

Catheter ablation

ECV:

Extracellular volume fraction

EF:

Ejection fraction

LGE:

Late gadolinium enhancement

LV:

Left ventricular

MRI:

Magnetic resonance imaging

NIDCM:

Non-ischemic dilated cardiomyopathy

ROC:

Receiver operating characteristics

References

  1. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bansch D, Investigators C-A (2018) Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 378(5):417–427. https://doi.org/10.1056/NEJMoa1707855

    Article  PubMed  Google Scholar 

  2. Prabhu S, Taylor AJ, Costello BT, Kaye DM, McLellan AJA, Voskoboinik A, Sugumar H, Lockwood SM, Stokes MB, Pathik B, Nalliah CJ, Wong GR, Azzopardi SM, Gutman SJ, Lee G, Layland J, Mariani JA, Ling LH, Kalman JM, Kistler PM (2017) Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI Study. J Am Coll Cardiol 70(16):1949–1961. https://doi.org/10.1016/j.jacc.2017.08.041

    Article  PubMed  Google Scholar 

  3. Iles LM, Ellims AH, Llewellyn H, Hare JL, Kaye DM, McLean CA, Taylor AJ (2015) Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. Eur Heart J Cardiovasc Imaging 16(1):14–22. https://doi.org/10.1093/ehjci/jeu182

    Article  PubMed  Google Scholar 

  4. aus dem Siepen F, Buss SJ, Messroghli D, Andre F, Lossnitzer D, Seitz S, Keller M, Schnabel PA, Giannitsis E, Korosoglou G, Katus HA, Steen H (2015) T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging 16(2):210–216. https://doi.org/10.1093/ehjci/jeu183

    Article  PubMed  Google Scholar 

  5. Nakamori S, Dohi K, Ishida M, Goto Y, Imanaka-Yoshida K, Omori T, Goto I, Kumagai N, Fujimoto N, Ichikawa Y, Kitagawa K, Yamada N, Sakuma H, Ito M (2018) Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy. JACC Cardiovasc Imaging 11(1):48–59. https://doi.org/10.1016/j.jcmg.2017.04.006

    Article  PubMed  Google Scholar 

  6. Puntmann VO, Carr-White G, Jabbour A, Yu CY, Gebker R, Kelle S, Hinojar R, Doltra A, Varma N, Child N, Rogers T, Suna G, Arroyo Ucar E, Goodman B, Khan S, Dabir D, Herrmann E, Zeiher AM, Nagel E, International TMCMROS (2016) T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure. JACC Cardiovasc Imaging 9(1):40–50. https://doi.org/10.1016/j.jcmg.2015.12.001

    Article  Google Scholar 

  7. Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S (2016) Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson 18(1):89. https://doi.org/10.1186/s12968-016-0308-4

    Article  PubMed  PubMed Central  Google Scholar 

  8. Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS, Mulukutla SR, Simon MA, Schelbert EB (2012) Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 126(10):1206–1216. https://doi.org/10.1161/CIRCULATIONAHA.111.089409

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1-39 e14. https://doi.org/10.1016/j.echo.2014.10.003

    Article  PubMed  Google Scholar 

  10. Lee K, Daimon M, Kuwabara Y, Hasegawa R, Toyoda T, Sekine T, Kawata T, Komuro I (2009) Prediction of the response to beta-blocker therapy in patients with dilated cardiomyopathy: comparison of 123I-MIBG scintigraphy and low-dose dobutamine stress echocardiography. J Echocardiogr 7(4):74–79. https://doi.org/10.1007/s12574-009-0022-4

    Article  PubMed  Google Scholar 

  11. Pinamonti B, Perkan A, Di Lenarda A, Gregori D, Sinagra G (2002) Dobutamine echocardiography in idiopathic dilated cardiomyopathy: clinical and prognostic implications. Eur J Heart Fail 4(1):49–61

    Article  PubMed  Google Scholar 

  12. Wilton SB, Fundytus A, Ghali WA, Veenhuyzen GD, Quinn FR, Mitchell LB, Hill MD, Faris P, Exner DV (2010) Meta-analysis of the effectiveness and safety of catheter ablation of atrial fibrillation in patients with versus without left ventricular systolic dysfunction. Am J Cardiol 106(9):1284–1291. https://doi.org/10.1016/j.amjcard.2010.06.053

    Article  PubMed  Google Scholar 

  13. Anselmino M, Matta M, D’Ascenzo F, Bunch TJ, Schilling RJ, Hunter RJ, Pappone C, Neumann T, Noelker G, Fiala M, Bertaglia E, Frontera A, Duncan E, Nalliah C, Jais P, Weerasooriya R, Kalman JM, Gaita F (2014) Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol 7(6):1011–1018. https://doi.org/10.1161/CIRCEP.114.001938

    Article  PubMed  Google Scholar 

  14. Dagres N, Varounis C, Gaspar T, Piorkowski C, Eitel C, Iliodromitis EK, Lekakis JP, Flevari P, Simeonidou E, Rallidis LS, Tsougos E, Hindricks G, Sommer P, Anastasiou-Nana M (2011) Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis. J Card Fail 17(11):964–970. https://doi.org/10.1016/j.cardfail.2011.07.009

    Article  PubMed  Google Scholar 

  15. Ganesan AN, Nandal S, Luker J, Pathak RK, Mahajan R, Twomey D, Lau DH, Sanders P (2015) Catheter ablation of atrial fibrillation in patients with concomitant left ventricular impairment: a systematic review of efficacy and effect on ejection fraction. Heart Lung Circ 24(3):270–280. https://doi.org/10.1016/j.hlc.2014.09.012

    Article  PubMed  Google Scholar 

  16. Liang JJ, Callans DJ (2018) Ablation for atrial fibrillation in heart failure with reduced ejection fraction. Card Fail Rev 4(1):33–37. https://doi.org/10.15420/cfr.2018:3:1

    Article  PubMed  PubMed Central  Google Scholar 

  17. Vita T, Grani C, Abbasi SA, Neilan TG, Rowin E, Kaneko K, Coelho-Filho O, Watanabe E, Mongeon FP, Farhad H, Rassi CH, Choi YL, Cheng K, Givertz MM, Blankstein R, Steigner M, Aghayev A, Jerosch-Herold M, Kwong RY (2018) Comparing CMR mapping methods and myocardial patterns toward heart failure outcomes in nonischemic dilated cardiomyopathy. JACC Cardiovasc Imaging. https://doi.org/10.1016/j.jcmg.2018.08.021

    Article  PubMed  PubMed Central  Google Scholar 

  18. Grani C, Biere L, Eichhorn C, Kaneko K, Agarwal V, Aghayev A, Steigner M, Blankstein R, Jerosch-Herold M, Kwong RY (2019) Incremental value of extracellular volume assessment by cardiovascular magnetic resonance imaging in risk stratifying patients with suspected myocarditis. Int J Cardiovasc Imaging 35(6):1067–1078. https://doi.org/10.1007/s10554-019-01552-6

    Article  PubMed  Google Scholar 

  19. Youn JC, Hong YJ, Lee HJ, Han K, Shim CY, Hong GR, Suh YJ, Hur J, Kim YJ, Choi BW, Kang SM (2017) Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study. Eur Radiol 27(9):3924–3933. https://doi.org/10.1007/s00330-017-4817-9

    Article  PubMed  Google Scholar 

  20. Yang EY, Ghosn MG, Khan MA, Gramze NL, Brunner G, Nabi F, Nambi V, Nagueh SF, Nguyen DT, Graviss EA, Schelbert EB, Ballantyne CM, Zoghbi WA, Shah DJ (2019) Myocardial extracellular volume fraction adds prognostic information beyond myocardial replacement fibrosis. Circ Cardiovasc Imaging 12(12):e009535. https://doi.org/10.1161/CIRCIMAGING.119.009535

    Article  PubMed  PubMed Central  Google Scholar 

  21. Gunasekaran S, Lee DC, Knight BP, Fan L, Collins JD, Chow K, Carr JC, Passman R, Kim D (2020) Left ventricular extracellular volume expansion is not associated with atrial fibrillation or atrial fibrillation-mediated left ventricular systolic dysfunction. Radiol Cardiothorac Imaging 2(2):e190096. https://doi.org/10.1148/ryct.2020190096

    Article  PubMed  PubMed Central  Google Scholar 

  22. Vassiliou VS, Heng EL, Gatehouse PD, Donovan J, Raphael CE, Giri S, Babu-Narayan SV, Gatzoulis MA, Pennell DJ, Prasad SK, Firmin DN (2016) Magnetic resonance imaging phantoms for quality-control of myocardial T1 and ECV mapping: specific formulation, long-term stability and variation with heart rate and temperature. J Cardiovasc Magn Reson 18(1):62. https://doi.org/10.1186/s12968-016-0275-9

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We are grateful to Masanori Ito, RT and Yuki Yoshimura, RT for CMR image acquisition.

Funding

Research Grant, Japan Society for the Promotion of Science: Grant-in-Aid for Early-Career Scientists.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shingo Kato.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest directly relevant to the content of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Azuma, M., Kato, S., Sekii, R. et al. Extracellular volume fraction by T1 mapping predicts improvement of left ventricular ejection fraction after catheter ablation in patients with non-ischemic dilated cardiomyopathy and atrial fibrillation. Int J Cardiovasc Imaging 37, 2535–2543 (2021). https://doi.org/10.1007/s10554-021-02219-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-021-02219-x

Keywords

Navigation